Cefotaxime – 30 μg Antibiotic Disc – Bioanalyse

Cefotaxime – 30 μg Antibiotic Disc – Bioanalyse Overview

The Cefotaxime – 30 μg Antibiotic Disc – Bioanalyse is a critical diagnostic tool for microbiology laboratories in Bangladesh. Specifically designed for the disc diffusion method, these precisely impregnated paper discs utilize 30 micrograms of Cefotaxime, a potent third-generation cephalosporin antibiotic. This method facilitates the determination of bacterial susceptibility to Cefotaxime, offering a straightforward yet effective approach to guiding antimicrobial therapy and combating a wide spectrum of bacterial infections. By assessing bacterial growth inhibition zones, healthcare professionals can make informed decisions for treating conditions ranging from pneumonia and UTIs to more severe infections like sepsis and meningitis.

Cefotaxime – 30 μg Antibiotic Disc – Bioanalyse Key Features

• Standardized Antibiotic Potency: Each disc contains a precise 30 μg concentration of Cefotaxime, ensuring consistent and reliable test results.
• Disc Diffusion Method Compatibility: Optimized for use in the widely accepted and cost-effective disc diffusion technique for antimicrobial susceptibility testing (AST).
• Clear Zone of Inhibition Measurement: Facilitates the accurate measurement of inhibition zones, crucial for interpreting bacterial susceptibility to Cefotaxime.
• Broad Applicability: Essential for diagnosing and managing a variety of bacterial infections, aiding in effective treatment selection.
• High-Quality Impregnation: Manufactured to rigorous standards to ensure the stability and efficacy of the antibiotic on the disc.
• Ease of Use: Simple to apply to agar plates, streamlining laboratory workflows.

Technical Specifications

• Product Name: Cefotaxime – 30 μg Antibiotic Disc
• Manufacturer: Bioanalyse
• Antibiotic: Cefotaxime
• Concentration: 30 μg per disc
• Method of Use: Disc Diffusion (Antimicrobial Susceptibility Testing)
• Interpretation Standards: Based on standard zone of inhibition diameters (Susceptible ≥ 27 mm, Intermediate 22-26 mm, Resistant < 22 mm).
• Quality Assurance: Manufactured under stringent quality control for consistent performance.
• Intended Use: For in vitro diagnostic use in determining bacterial susceptibility to Cefotaxime.